Kinnate Biopharma Inc (KNTE) Stock Rises 0.89% This Week; Should You Buy?

Monday, October 30, 2023 10:28 AM | InvestorsObserver Analysts

Mentioned in this article

Kinnate Biopharma Inc (KNTE) Stock Rises 0.89% This Week; Should You Buy?

Kinnate Biopharma Inc (KNTE) stock has fallen -86.60% over the last 12 months, and the average rating from Wall Street analysts is a Buy. InvestorsObserver’s proprietary ranking system, gives KNTE stock a score of 35 out of a possible 100.

That rank is influenced by a short-term technical score of 4. KNTE's rank also includes a long-term technical score of 8.

KNTE has an Overall Score of 35. Find out what this means to you and get the rest of the rankings on KNTE!

See Full KNTE Report

What's Happening with KNTE Stock Today

Kinnate Biopharma Inc (KNTE) stock is higher by 5.61% while the S&P 500 has risen 0.56% as of 10:24 AM on Monday, Oct 30. KNTE has risen $0.06 from the previous closing price of $1.07 on volume of 24,808 shares. Over the past year the S&P 500 has risen 6.93% while KNTE has fallen -86.60%. KNTE lost -$2.82 per share in the over the last 12 months. Click Here to get the full Stock Report for Kinnate Biopharma Inc stock.